How much funding has Moderna raised?

Moderna has raised $1.1B in total funding, most recently a Series F round.

Who are Moderna's investors?

Moderna's investors include Flagship Pioneering, Coalition for Epidemic Preparedness Innovations (CEPI), Abu Dhabi Investment Authority, BB Biotech AG, Viking Global, Invus.

Where is Moderna headquartered?

Moderna is headquartered in Cambridge, Massachusetts.

What industry is Moderna in?

Moderna operates in Biotech, Healthcare.

How many employees does Moderna have?

Moderna has 1001-5000 employees.

Moderna

IPO

Pioneering mRNA technology

Public · Cambridge · Founded 2010 · $1.1B raised

Biotech

Healthcare

Headquarters: Cambridge, Massachusetts
Employees: 1001–5000
Founded: 2010
Business Model: B2B
Website: modernatx.com

Total Funding: $1.1B
Last Round: $500.0M Series FJan 2018
Rounds: 5
Type: Public

About

Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. Founded in September 2010, the company pioneered the development of mRNA-based medicines, culminating in the Moderna COVID-19 vaccine (Spikevax). The company's pipeline spans 44 candidates including vaccines for influenza, RSV (Mresvia, FDA-approved 2024), HIV, and cancer (mRNA-4157 personalized cancer vaccine in partnership with Merck). Moderna operates manufacturing facilities in Massachusetts and employs approximately 4,800 people worldwide as of 2025.

Summary

Moderna is a Biotech company based in Cambridge, founded in 2010. It has raised $1.1B in total across 5 rounds, most recently a $500.0M Series F round in Jan 2018. Investors include Flagship Pioneering, Coalition for Epidemic Preparedness Innovations (CEPI) and Abu Dhabi Investment Authority.

LinkedIn X (Twitter)